Zum Nutzen internationaler Standards bei der Vergabe von Genpatenten - Eine vergleichende Analyse am Beispiel der EU und Japans

The benefits of international standards in the awarding of genetic patents - A comparative analysis between the EU and Japan

Bernard Gilroy and Tobias Vollpert

MPRA Paper from University Library of Munich, Germany

Abstract: The specific characteristics of the R&D system of the modern molecular biotechnology lead to the fact that patent protection for genetic inventions cause almost simultaneously an useful information effect as well as a harmful blocking effect. Within this context, the present papers shows that the current attempts of the U.S., Japan, and the EU to establish consistent standards for patents in the area of genetic engineering, are only scarcely reasonable. Due to national distinctions of cultural and traditional conditions with view to the allocation and usage of property rights, an optimal patent system in Japan is not identical to one in Europe or the U.S.

Keywords: Patents; biotechnology; international harmonization (search for similar items in EconPapers)
JEL-codes: K11 K33 O31 O34 (search for similar items in EconPapers)
Date: 2003-10
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/18671/1/MPRA_paper_18671.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:18671

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().